Back
Editas Medicine Stock Price Chart

Trade Alert: Your First Two (Money Doubling?) Trades
Claim your first two trades here.
Sell
26
EDIT
Editas Medicine
Last Price:
$2.20
Seasonality Move:
-16.44%
7 Day Trial
ALL ACCESS PASS
$
7

Access Before Tuesday...
Grab your first two primed-to-double trades here.-
The current trend is moderately bullish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.48 | Sell |
20-day SMA: | 2.79 | Sell |
50-day SMA: | 2.45 | Sell |
200-day SMA: | 1.94 | Buy |
8-day EMA: | 2.19 | Buy |
20-day EMA: | 1.47 | Buy |
50-day EMA: | 0.75 | Buy |
200-day EMA: | 0.21 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.68 | Buy |
Relative Strength Index (14 RSI): | 37.83 | Sell |
Chaikin Money Flow: | -2132720 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.5 - 3.12) | Sell |
Bollinger Bands (100): | (1.29 - 2.55) | Buy |
Editas Medicine Technical Analysis
Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 2.21 while EDIT 8-day simple moving average is 2.48, which is a Sell signal.
-
The stock price of EDIT is 2.21 while Editas Medicine 20-day SMA is 2.79, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 2.45 while EDIT share price is 2.21, making it a Sell technically.
-
EDIT stock price is 2.21 and Editas Medicine 200-day simple moving average is 1.94, creating a Buy signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
26
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $2.21. The Score for EDIT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
185M
Price in USD:
2.21
Share Volume:
2.3M
Editas Medicine 52-Week Range
52-Week High:
4.22
52-Week Low:
0.91
Sell
26
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 2.21 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 2.21 while EDIT 8-day exponential moving average is 2.19, which is a Buy signal.
-
The stock price of EDIT is 2.21 while Editas Medicine 20-day EMA is 1.47, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 0.75 while EDIT share price is 2.21, making it a Buy technically.
-
EDIT stock price is 2.21 and Editas Medicine 200-day simple moving average is 0.21, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.08 per share, an increase this year of $0.82 per share, and an increase next year of $0.69 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 37.83, which suggest Editas Medicine is oversold
-
The Bollinger Bands (25) for Editas Medicine is (2.5 - 3.12), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.29 - 2.55), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.